That sounds like a good thing and it is. But it’s not a US story. In fact, other wealthy countries didn’t just already have a higher baseline life expectancy pre-COVID, they rebounded to it post-COVID sooner than the U.S. was able to its already lower level.

So what this actually is, is a story of “global modern medicine good”, and unfortunately, even within that, the U.S. is among the worst performing.